Canadian isotope supplier MDS Nordion has received regulatory go-aheads from the U.S. Food and Drug Administration and the Health Canada agency for its Monte Carlo electron-radiotherapy treatment-calculation technique. According to the Kanata, Ontario vendor, the software will provide greater accuracy in calculating the dose required for cancer patients receiving radiation therapy. The company will be using the dose-calculation algorithms in its Oncentra treatment-planning software.
By AuntMinnie.com staff writers
July 11, 2002
Related Reading
MDS Nordion focuses on oncology software solutions, June 28, 2002
Varian to buy MDS Nordion's brachytherapy unit, June 27, 2002
MDS expands manufacturing facilities, June 12, 2002
MDS Nordion shows oncology info management system, November 5, 2001
Copyright © 2002 AuntMinnie.com
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
